Lataa...
Hypomethylating agents after allogeneic blood stem cell transplantation
Allogeneic blood stem cell transplantation (allo-SCT) is a potentially curative treatment for patients with myeloid malignancies such as acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), but relapse remains the major cause of treatment failure. So far, therapeutic options for patient...
Tallennettuna:
| Julkaisussa: | Stem Cell Investig |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
AME Publishing Company
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5182210/ https://ncbi.nlm.nih.gov/pubmed/28066786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/sci.2016.11.04 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|